Sichenzia Ross Ference LLP Acts as Principal Attorney Liaison for Zelda Therapeutics Ltd on OTCQX Listing

Press Release – New York, NY – September 14, 2018 – Sichenzia Ross Ference LLP announced today that it has sponsored Zelda Therapeutics Ltd (OTCQX: “ZLDAF”), an Australian biotechnology company studying the use of medicinal cannabis to treat a variety of ailments, for the OTCQX.

Sichenzia Ross Ference is a qualified firm responsible for providing guidance on OTCQX requirements and recommending membership.  The Sichenzia Ross Ference team was led by Partner Darrin Ocasio.